260 related articles for article (PubMed ID: 34857659)
1. Diagnostic Performance of Cervical Ultrasound,
Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
[TBL] [Abstract][Full Text] [Related]
2.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
Dudoignon D; Delbot T; Cottereau AS; Dechmi A; Bienvenu M; Koumakis E; Cormier C; Gaujoux S; Groussin L; Cochand-Priollet B; Clerc J; Wartski M
Diagn Interv Imaging; 2022 May; 103(5):258-265. PubMed ID: 35039246
[TBL] [Abstract][Full Text] [Related]
4.
Cuderman A; Senica K; Rep S; Hocevar M; Kocjan T; Sever MJ; Zaletel K; Lezaic L
J Nucl Med; 2020 Apr; 61(4):577-583. PubMed ID: 31562221
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
[TBL] [Abstract][Full Text] [Related]
6. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
[TBL] [Abstract][Full Text] [Related]
7.
Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
[TBL] [Abstract][Full Text] [Related]
8. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
Uslu-Beşli L; Sonmezoglu K; Teksoz S; Akgun E; Karayel E; Pehlivanoglu H; Khosroshahi BR; Ocak M; Kabasakal L; Sager S; Bukey Y
Korean J Radiol; 2020 Feb; 21(2):236-247. PubMed ID: 31997599
[TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
Thanseer N; Bhadada SK; Sood A; Mittal BR; Behera A; Gorla AKR; Kalathoorakathu RR; Singh P; Dahiya D; Saikia UN; Rao SD
Clin Nucl Med; 2017 Dec; 42(12):e491-e497. PubMed ID: 28902729
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas.
Noltes ME; Rotstein L; Eskander A; Kluijfhout WP; Bongers P; Brouwers AH; Kruijff S; Metser U; Pasternak JD; Veit-Haibach P
Langenbecks Arch Surg; 2023 Apr; 408(1):155. PubMed ID: 37079138
[TBL] [Abstract][Full Text] [Related]
12.
Gass JM; Wicke C; Mona C; Strobel K; Müller W; Metzger J; Suter-Widmer I; Henzen C; Fischli S
Endocrine; 2022 Feb; 75(2):593-600. PubMed ID: 34561784
[TBL] [Abstract][Full Text] [Related]
13. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
[TBL] [Abstract][Full Text] [Related]
14. Does
Imperiale A; Bani J; Bottoni G; Latgé A; Heimburger C; Catrambone U; Vix M; Treglia G; Piccardo A
Front Med (Lausanne); 2023; 10():1148287. PubMed ID: 37181366
[TBL] [Abstract][Full Text] [Related]
15. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
[TBL] [Abstract][Full Text] [Related]
16. Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism.
Tlili G; Mesguich C; Gaye D; Tabarin A; Haissaguerre M; Hindié E
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):114-121. PubMed ID: 36748984
[TBL] [Abstract][Full Text] [Related]
17. Preoperative imaging in primary hyperparathyroidism: Are
Christensen JW; Ismail A; Søndergaard SB; Bennedbaek FN; Nygaard B; Jensen LT; Trolle W; Holst-Hahn C; Zerahn B; Kristensen B; Krakauer M
Clin Endocrinol (Oxf); 2022 Sep; 97(3):258-267. PubMed ID: 35150160
[TBL] [Abstract][Full Text] [Related]
18. Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients.
Morland D; Lalire P; Deguelte S; Zalzali M; Richard C; Dejust S; Boulagnon C; Ly S; Papathanassiou D; Delemer B
Medicine (Baltimore); 2020 Jan; 99(2):e18681. PubMed ID: 31914064
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of ultrasonography, dual-phase
Zhang R; Zhang Z; Huang P; Li Z; Hu R; Zhang J; Qiu W; Hu P
BMC Med Imaging; 2020 Aug; 20(1):91. PubMed ID: 32746794
[TBL] [Abstract][Full Text] [Related]
20.
Gauthé M; Dierick-Gallet A; Delbot T; Bricaire L; Bertherat J; North MO; Cochand-Priollet B; Bouchard P; Talbot JN; Groussin L; Gaujoux S
World J Surg; 2020 Nov; 44(11):3761-3769. PubMed ID: 32681321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
